Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer.

Journal of surgical oncology - 1 Jun 2014

Demir Lutfiye, Ekinci Nese, Erten Cigdem, Somali Isil, Can Alper, Dirican Ahmet, Cokmert Suna, Bayoglu Vedat, Akyol Murat, Kucukzeybek Yuksel, Alacacioglu Ahmet, Tarhan Mustafa Oktay

Abstract excerpt

BACKGROUND AND OBJECTIVES: We aimed to evaluate the prognostic value of cell cycle proteins and p53 together with clinicopathologic features in non-metastatic resected colon cancer. METHODS: One hundred nine patients who were diagnosed with resected colon cancer between 2006 and 2011 were analyzed retrospectively. Immunohistochemical staining analyses were used to evaluate the expression of cyclins D1 and A, p53...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclin A

Share to Cyclin D1

Share to Genes, p53

Share to Ki-67 Antigen

Share to Neoplasm Recurrence, Local

Share to Proportional Hazards Models

Source

Identifiers

PMID: 24464927
DOI: 10.1002/jso.23563

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer.PMID 24464927Read ↗

Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.Semantic proximity Read ↗

A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer CasesSemantic proximity Read ↗

The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.Semantic proximity Read ↗

Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial.Semantic proximity Read ↗

Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma.Semantic proximity Read ↗

Markers of drug resistance in relapsing colon cancer.Semantic proximity Read ↗

Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomasSemantic proximity Read ↗

[K-ras mutational status and tumour-infiltrating lymphocytes in human colon cancer: state of the art and future perspectives].Semantic proximity Read ↗

Analysis of key cell‐cycle checkpoint proteins in colorectal tumoursSemantic proximity Read ↗

Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.Semantic proximity Read ↗

p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy.Semantic proximity Read ↗

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.